Skip to main content

Harpoon Therapeutics, Inc.

HARPDelisted Mar 11, 2024
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001708493

Harpoon Therapeutics, Inc. was delisted on Mar 11, 2024; its insiders filed their last Form 4 on Mar 11, 2024; 41 institutions reported holding it in 13F filings for Q4 2023, worth $175.5M in total; no superinvestor held it.

Q2 2021 vs. Q1 2021

How the institutions holding Harpoon Therapeutics, Inc. changed between Q1 2021 and Q2 2021.

All holders in Q2 2021All holders in Q1 2021

13F holders of HARP: Q1 2021 compared with Q2 2021
MeasureQ1 2021Q2 2021Change
Holders8885−3
Shares26.9M28.7M+1.80M (+6.7%)
Value$562.3M$357.3M−$205.0M (−36.5%)

New holders (10)

Institutions that held Harpoon Therapeutics, Inc. at the end of Q2 2021 but not at the end of Q1 2021.

Institutions new to HARP in Q2 2021
InstitutionSharesValue% of portfolio
VR Adviser, LLC512,005$7.10M0.86%
Rafferty Asset Management, LLC59,549$826.0K0.01%
Qube Research & Technologies Ltd54,029$749.0K0.01%
Engineers Gate Manager LP18,220$253.0K0.02%
Jane Street Group, LLC13,848$192.0K0.00%
Manufacturers Life Insurance Company, The12,036$167.0K0.00%
XTX Topco Ltd10,898$151.0K0.05%
ProShare Advisors LLC10,697$148.0K0.00%
Parametric Portfolio Associates LLC10,509$146.0K0.00%
Point72 Hong Kong Ltd1,611$22.0K0.00%

Sold out (13)

Institutions that held Harpoon Therapeutics, Inc. at the end of Q1 2021 and filed for Q2 2021 without it.